Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Wunderlich

Showing results (121-130 of 142) with videos related to

Pageof 15
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2015
Identification of an Immunogenic Subset of Metastatic Uveal MelanomaLuke D Rothermel, Arvind C Sabesan, Daniel J Stephens, et al.
The Journal of Thoracic and Cardiovascular Surgery|June 30, 2010
Thoracic metastasectomy for adoptive immunotherapy of melanoma: a single-institution experienceJacob A Klapper, Jeremy L Davis, R Taylor Ripley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2018
A Phase II Study of Tumor-infiltrating Lymphocyte Therapy for Human Papillomavirus-associated Epithelial CancersSanja Stevanović, Sarah R Helman, John R Wunderlich, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 1999
Impact of cytokine administration on the generation of antitumor reactivity in patients with metastatic melanoma receiving a peptide vaccineS A Rosenberg, J C Yang, D J Schwartzentruber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2003
Recombinant fowlpox viruses encoding the anchor-modified gp100 melanoma antigen can generate antitumor immune responses in patients with metastatic melanomaSteven A Rosenberg, James C Yang, Douglas J Schwartzentruber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 19, 2011
Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapySteven A Rosenberg, James C Yang, Richard M Sherry, et al.
Nature Medicine|March 21, 1998
Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanomaS A Rosenberg, J C Yang, D J Schwartzentruber, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 10, 2002
A phase I study of nonmyeloablative chemotherapy and adoptive transfer of autologous tumor antigen-specific T lymphocytes in patients with metastatic melanomaMark E Dudley, John R Wunderlich, James C Yang, et al.
Science (New York, N.Y.)|September 2, 2006
Cancer regression in patients after transfer of genetically engineered lymphocytesRichard A Morgan, Mark E Dudley, John R Wunderlich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 6, 2017
Characterization of an Immunogenic Mutation in a Patient with Metastatic Triple-Negative Breast CancerYasmine Assadipour, Nikolaos Zacharakis, Jessica S Crystal, et al.
Pageof 15

Showing results (121-130 of 142) with videos related to

Sort By:
Pageof 15
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2015
Identification of an Immunogenic Subset of Metastatic Uveal MelanomaLuke D Rothermel, Arvind C Sabesan, Daniel J Stephens, et al.
The Journal of Thoracic and Cardiovascular Surgery|June 30, 2010
Thoracic metastasectomy for adoptive immunotherapy of melanoma: a single-institution experienceJacob A Klapper, Jeremy L Davis, R Taylor Ripley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2018
A Phase II Study of Tumor-infiltrating Lymphocyte Therapy for Human Papillomavirus-associated Epithelial CancersSanja Stevanović, Sarah R Helman, John R Wunderlich, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 1999
Impact of cytokine administration on the generation of antitumor reactivity in patients with metastatic melanoma receiving a peptide vaccineS A Rosenberg, J C Yang, D J Schwartzentruber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2003
Recombinant fowlpox viruses encoding the anchor-modified gp100 melanoma antigen can generate antitumor immune responses in patients with metastatic melanomaSteven A Rosenberg, James C Yang, Douglas J Schwartzentruber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 19, 2011
Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapySteven A Rosenberg, James C Yang, Richard M Sherry, et al.
Nature Medicine|March 21, 1998
Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanomaS A Rosenberg, J C Yang, D J Schwartzentruber, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 10, 2002
A phase I study of nonmyeloablative chemotherapy and adoptive transfer of autologous tumor antigen-specific T lymphocytes in patients with metastatic melanomaMark E Dudley, John R Wunderlich, James C Yang, et al.
Science (New York, N.Y.)|September 2, 2006
Cancer regression in patients after transfer of genetically engineered lymphocytesRichard A Morgan, Mark E Dudley, John R Wunderlich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 6, 2017
Characterization of an Immunogenic Mutation in a Patient with Metastatic Triple-Negative Breast CancerYasmine Assadipour, Nikolaos Zacharakis, Jessica S Crystal, et al.
Pageof 15